| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Revenue | $27.3M | +24.1% |
| Cost of Revenue | $11.0M | -9.2% |
| Gross Profit | $16.4M | +64.7% |
| R&D Expense | $8.9M | -35.5% |
| SG&A Expense | $8.8M | -9.9% |
| Operating Income | -$9.4M | +56.3% |
| Pre-tax Income | -$7.4M | +65.7% |
| Income Tax | -$15K | -125.9% |
| Net Income | -$7.4M | +65.9% |
| EPS (Basic) | -$0.16 | +72.4% |
| EPS (Diluted) | -$0.16 | +72.4% |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.5M | +199.3% |
| Accounts Receivable | $8.8M | +45.8% |
| Current Assets | $37.8M | +46.1% |
| Total Assets | $55.2M | +9.5% |
| Current Liabilities | $11.1M | -8.7% |
| Total Liabilities | $12.7M | -32.8% |
| Stockholders' Equity | $42.5M | +34.8% |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.7M | +49.3% |
| Capital Expenditures | $646K | +97.0% |
| Investing Cash Flow | -$394K | -109.8% |
| Financing Cash Flow | $17.6M | +613.5% |
| Free Cash Flow | -$5.4M | +44.3% |